Biophysical insight into the anti-amyloidogenic behavior of taurine

International Journal of Biological Macromolecules

Volumn 80, Issue , 2015, Pages 375-384

  Chaturvedi, Sumit Kumar ^a   Alam, Parvez ^a   Khan, Javed Masood ^a   Siddiqui, Mohd Khursheed ^a   Kalaiarasan, Ponnusamy ^b   Subbarao, Naidu ^b   Ahmad, Zeeshan ^a   Khan, Rizwan Hasan ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Aggregation; Amyloid fibril; HSA; Taurine

Indexed keywords

HUMAN SERUM ALBUMIN; TAURINE; THIOFLAVINE; AMYLOID; PROTEIN AGGREGATE; PROTEIN BINDING; SERUM ALBUMIN;

ALPHA HELIX; ARTICLE; BINDING ASSAY; CIRCULAR DICHROISM; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; FLUORESCENCE MICROSCOPY; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; IN VITRO STUDY; LIGHT SCATTERING; MOLECULAR DOCKING; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; STRUCTURE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; TURBIDIMETRY; ULTRAVIOLET SPECTROSCOPY; ANIMAL; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECTS; HUMAN; KINETICS; MOLECULAR DYNAMICS; PC12 CELL LINE; RAT;

AMYLOID; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL SURVIVAL; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KINETICS; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; PC12 CELLS; PROTEIN AGGREGATES; PROTEIN BINDING; RATS; SERUM ALBUMIN; TAURINE;

EID: 84942927804     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2015.06.035     Document Type: Article

References (56)

1. Fink A.L. Protein aggregation: folding aggregates, inclusion bodies and amyloid. Folding Des. 1998, 3. R9-R23.
2. Raleigh D.P. Guilt by association: the physical chemistry and biology of protein aggregation. J. Phys. Chem. Lett. 2014, 5:2012-2014.
3. Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat. Rev. Mol. Cell Biol. 2007, 8:101-112.
4. M. Maheshwari, S. Shekhar, B.K. Singh, I. Jamal, N. Vatsa, V. Kumar, A. Sharma, N.R. Jana, Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology, Hum. Mol. Genet. (2014) ddu343.
5. Ross C.A., Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004.
6. Shigihara N., Fukunaka A., Hara A., Komiya K., Honda A., Uchida T., Abe H., Toyofuku Y., Tamaki M., Ogihara T. Human IAPP-induced pancreatic b cell toxicity and its regulation by autophagy. J. Clin. Investig. 2014, 124:3634.
7. Schwendeman S.P. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 2002, 19.
8. Khan J.M., Chaturvedi S.K., Rahman S.K., Ishtikhar M., Qadeer A., Ahmad E., Khan R.H. Protonation favors aggregation of lysozyme with SDS. Soft Matter 2014, 10:2591-2599.
9. Sancataldo G., Vetri V., Foderà V., Di Cara G., Militello V., Leone M. Oxidation enhances human serum albumin thermal stability and changes the routes of amyloid fibril formation. PloS One 2014, 9:e84552.
10. Breydo L., Reddy K.D., Piai A., Felli I.C., Pierattelli R., Uversky V.N. The crowd you're in with: effects of different types of crowding agents on protein aggregation. Biochim. Biophys. Acta (BBA)-Proteins Proteomics 2014, 1844:346-357.
11. Knowles T.P.J., Vendruscolo M., Dobson C.M. The amyloid state and its association with protein misfolding diseases. Nat. Rev. Mol. Cell Biol. 2014, 15:384-396.
12. Regitz C., Marie Dußling L., Wenzel U. Amyloid-beta (Ab-42) induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways. Mol. Nutr. Food Res. 2014.
13. Abraham J.N., Kedracki D., Prado E., Gourmel C., Maroni P., Nardin C. Effect of the interaction of the amyloid b (1-42) peptide with short single stranded synthetic nucleotide sequences: morphological characterization of the inhibition of fibrils formation and fibrils disassembly. Biomacromolecules 2014.
14. Nadimpally K.C., Paul A., Mandal B. Reversal of aggregation using b-breaker dipeptide containing peptides: application to Ab (1-40) self-assembly and its inhibition. ACS Chem. Neurosci. 2014, 5:400-408.
15. Varshney A., Ansari Y., Zaidi N., Ahmad E., Badr G., Alam P., Khan R.H. Analysis of binding interaction between antibacterial ciprofloxacin and human serum albumin by spectroscopic techniques. Cell Biochem. Biophys. 2014, 70:93-101.
16. Bhattacharya S., Pandey N.K., Roy A., Dasgupta S. Effect of (-)-epigallocatechin gallate on the fibrillation of human serum albumin. Int. J. Biol. Macromol. 2014, 70:312-319.
17. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 1992, 72:101-163.
18. Froger N., Moutsimilli L., Cadetti L., Jammoul F., Wang Q.-P., Fan Y., Gaucher D., Rosolen S.G., Neveux N., Cynober L. Taurine: the comeback of a neutraceutical in the prevention of retinal degenerations. Prog. Retinal Eye Res. 2014.
19. Menzie J., Pan C., Prentice H., Wu J.-Y. Taurine and central nervous system disorders. Amino Acids 2014, 46:31-46.
20. Schaffer S.W., Ito T., Azuma J. Clinical significance of taurine. Amino Acids 2014, 46:1-5.
21. Imae M., Asano T., Murakami S. Potential role of taurine in the prevention of diabetes and metabolic syndrome. Amino Acids 2014, 46:81-88.
22. Venkatachalam S., Kuppusamy P., Kuppusamy B., Dhanapal S. The potency of essential nutrient taurine on boosting the antioxidant status and chemopreventive effect against benzo (a) pyrene induced experimental lung cancer. Biomed. Prevent. Nutr. 2014, 4:251-255.
23. Park E., Park S.Y., Dobkin C., Schuller-Levis G. Development of a novel cysteine sulfinic acid decarboxylase knockout mouse: dietary taurine reduces neonatal mortality. J. Amino Acids 2014, 2014.
24. Juarez J., Taboada P., Mosquera V. Existence of different structural intermediates on the fibrillation pathway of human serum albumin. Biophys. J. 2009, 96:2353-2370.
25. Freire S., de Araujo M.H., Al-Soufi W., Novo M. Photophysical study of Thioflavin T as fluorescence marker of amyloid fibrils. Dyes Pigments 2014.
26. Wang S.S.S., Liu K.-N., Wu C.-H., Lai J.-K. Investigating the influences of redox buffer compositions on the amyloid fibrillogenesis of hen egg-white lysozyme. Biochim. Biophys. Acta (BBA)-Proteins Proteomics 2009, 1794:1663-1672.
27. Qadeer A., Ahmad E., Zaman M., Khan M.W., Khan J.M., Rabbani G., Tarique K.F., Sharma G., Gourinath S., Nadeem S., Badr G., Khan R.H. Concentration-dependent antagonistic persuasion of SDS and naphthalene derivatives on the fibrillation of stem bromelain. Arch Biochem. Biophys. 2013, 540:101-116.
28. Hopping G., Kellock J., Barnwal R.P., Law P., Bryers J., Varani G., Caughey B., Daggett V. Designed alpha-sheet peptides inhibit amyloid formation by targeting toxic oligomers. Elife 2014, 3:e01681.
29. Van Der Spoel D., Lindahl E., Hess B., Groenhof G., Mark A.E., Berendsen H.J. GROMACS: fast, flexible, and free. J. Comput. Chem. 2005, 26:1701-1718.
30. Scott W.R.P., Hãnenberger P.H., Tironi I.G., Mark A.E., Billeter S.R., Fennen J., Torda A.E., Huber T., Krãger P., van Gunsteren W.F. The GROMOS biomolecular simulation program package. J. Phys. Chem. A 1999, 103:3596-3607.
31. Pullman B., Berendsen H.J.C., Postma J.P.M., van Gunsteren W.F., Hermans J. Interaction Models for Water in Relation to Protein Hydration Intermolecular Forces 1981, vol. 14:331-342. Springer, Netherlands.
32. Hess B., Bekker H., Berendsen H.J.C., Fraaije J.G.E.M. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 1997, 18:1463-1472.
33. Zaidi N., Ajmal M.R., Rabbani G., Ahmad E., Khan R.H. A comprehensive insight into binding of hippuric acid to human serum albumin: a study to uncover its impaired elimination through hemodialysis. PloS One 2013, 8:e71422.
34. Khurana R., Coleman C., Ionescu-Zanetti C., Carter S.A., Krishna V., Grover R.K., Roy R., Singh S. Mechanism of thioflavin T binding to amyloid fibrils. J. Struct. Biol. 2005, 151:229-238.
35. Li S., Wang L., Chusuei C.C., Suarez V.M., Blackwelder P.L., Micic M., Orbulescu J., Leblanc R.M. Nontoxic carbon dots potently inhibit human insulin fibrillation. Chem. Mater. 2015, 27:1764-1771.
36. Lian H.-Y., Zhang H., Zhang Z.-R., Loovers H.t.M., Jones G.W., Rowling P.J.E., Itzhaki L.S., Zhou J.-M., Perrett S. Hsp40 interacts directly with the native state of the yeast prion protein Ure2 and inhibits formation of amyloid-like fibrils. J. Biol. Chem. 2007, 282:11931-11940.
37. Gong H., He Z., Peng A., Zhang X., Cheng B., Sun Y., Zheng L., Huang K. Effects of several quinones on insulin aggregation. Sci. Rep. 2014, 4.
38. Wu J.W., Liu K.-N., How S.-C., Chen W.-A., Lai C.-M., Liu H.-S., Hu C.-J., Wang S.S.S. Carnosine's effect on amyloid fibril formation and induced cytotoxicity of lysozyme. PloS One 2013, 8:e81982.
39. Kisilevsky R., Lemieux L.J., Fraser P.E., Kong X., Hultin P.G., Szarek W.A. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat. Med. 1995, 1:143-148.
40. Owczarz M., Arosio P. Sulfate anion delays the self-assembly of human insulin by modifying the aggregation pathway. Biophys. J. 2014, 107:197-207.
41. 2-protein fibrils using biocompatible nanogels as artificial chaperones. FEBS Lett. 2006, 580:6587-6595.
42. Taboada P., Barbosa S., Castro E., Mosquera V.c. Amyloid fibril formation and other aggregate species formed by human serum albumin association. J. Phys. Chem. B 2006, 110:20733-20736.
43. Ghosh S., Pandey N.K., Banerjee P., Chaudhury K.N., Veronika Nagy r., Dasgupta S. Copper (II) directs formation of toxic amorphous aggregates resulting in inhibition of hen egg white lysozyme fibrillation under alkaline salt mediated conditions. J. Biomol. Struct. Dyn. 2014, 1-54.
44. 4 nanoparticles on fibrillation of human serum albumin. J. Phys. Chem. B 2014, 118:11667-11676.
45. Armstrong J.K., Wenby R.B., Meiselman H.J., Fisher T.C. The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. Biophys. J. 2004, 87:4259-4270.
46. Khan J.M., Chaturvedi S.K., Khan R.H. Elucidating the mode of action of urea on mammalian serum albumins and protective effect of sodium dodecyl sulfate. Biochem. Biophys. Res. Commun. 2014, 441:681-688.
47. Chaturvedi S.K., Ahmad E., Khan J.M., Alam P., Ishtikhar M., Khan R.H. Elucidating the interaction of limonene with bovine serum albumin: a multi-technique approach. Mol. BioSyst. 2014.
48. Chaturvedi S.K., Ahmad E., Khan J.M., Alam P., Ishtikhar M., Khan R.H. Elucidating the interaction of limonene with bovine serum albumin: a multi-technique approach. Mol. BioSyst. 2015, 11:307-316.
49. Hoyer W., Antony T., Cherny D., Heim G., Jovin T.M., Subramaniam V. Dependence of alpha-synuclein aggregate morphology on solution conditions. J. Mol. Biol. 2002, 322:383-393.
50. Ghosh S., Pandey N.K., Dasgupta S. Crowded milieu prevents fibrillation of hen egg white lysozyme with retention of enzymatic activity. J. Photochem. Photobiol. B: Biol. 2014, 138:8-16.
51. Garg A., Manidhar D.M., Gokara M., Malleda C., Suresh Reddy C., Subramanyam R. Elucidation of the binding mechanism of coumarin derivatives with human serum albumin. PLoS One 2013, 8:e63805.
52. Zsila F. Subdomain IB is the third major drug binding region of human serum albumin: toward the three-sites model. Mol. Pharm. 2013, 10:1668-1682.
53. Hein K.L., Kragh-Hansen U., Morth J.P., Jeppesen M.D., Otzen D., Møller J.V., Nissen P., Nissen Crystallographic analysis reveals a unique lidocaine binding site on human serum albumin. J. Struct. Biol. 2010, 171:353-360.
54. Alam P., Chaturvedi S.K., Anwar T., Siddiqi M.K., Ajmal M.R., Badr G., Mahmoud M.H., Hasan Khan R. Biophysical and molecular docking insight into the interaction of cytosine β-d arabinofuranoside with human serum albumin. J. Lumin. 2015, 164:123-130.
55. Yeggoni D.P., Subramanyam R. Binding studies of l-3,4-dihydroxyphenylalanine with human serum albumin. Mol. BioSyst. 2014, 10:3101-3110.
56. Malleda C., Ahalawat N., Gokara M., Subramanyam R. Molecular dynamics simulation studies of betulinic acid with human serum albumin. J. Mol. Model 2014, 18:2589-2597.